Voters across the state of Utah identified healthcare – and healthcare costs – as their top concern in Utah Foundation’s 2016 Utah Priorities Project. Increasingly expensive drugs have helped to push the overall cost higher. Unscrupulous companies that have cornered the market for some important generic drugs and dramatically raised their prices has only made the situation more complicated.
In January, the CEO of Intermountain Healthcare announced a joint effort by several non-profit hospital systems to stand up to this kind of abuse in the market by manufacturing their own generic drugs. The effort is winning applause from some large pharmaceutical companies and from other hospital systems.
In this edition of Utah Thrives, we hear from Intermountain Healthcare Vice President Dan Liljenquist and from Erin Fox, the Director of Drug Information for University of Utah Healthcare.
Podcast: Play in new window | Download
Subscribe: RSS
Categories: